New Key Statistics Module, Z-Score and F-Score
NAS:RIGL Key Ratios
| Market Cap $ M | 289.59 |
| Enterprise Value $ M | 288.70 |
| P/E(ttm) | 71.48 |
| PE Ratio without NRI | 71.48 |
| Forward PE Ratio | 16.83 |
| Price/Book | -- |
| Price/Sales | 1.82 |
| Price/Free Cash Flow | 28.29 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 157.00 |
| EPS (TTM) $ | 0.23 |
| Beneish M-Score | -2.22 |
| 10-y EBITDA Growth Rate % | 21.00 |
| 5-y EBITDA Growth Rate % | 22.80 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 25.63 |
| EV-to-EBITDA | 22.04 |
| PEG | 3.14 |
| Shares Outstanding M | 17.62 |
| Net Margin (%) | 2.47 |
| Operating Margin % | 6.04 |
| Pre-tax Margin (%) | 2.47 |
| Quick Ratio | 1.87 |
| Current Ratio | 1.96 |
| ROA % (ttm) | 3.10 |
| ROE % (ttm) | 10,000.00 |
| ROIC % (ttm) | 14.02 |
| Dividend Yield % | -- |
| Altman Z-Score | -11.07 |
RIGL Number of Guru Trades
RIGL Volume of Guru Trades
Gurus Latest Trades with NAS:RIGL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RIGL is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Rigel Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:RIGL
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers